Inventor · disambiguated record
Mark Keating
Also filed as: KEATING MARK · KEATING MARK T · KEATING MARK TAYLOR
31 granted patents·23 pending applications·307 citations·filing 1995–2024
97Inventor score
Files withUNIV UTAH RES FOUND29ALNYLAM PHARMACEUTICALS INC15NOVARTIS AG3CHILDRENS MEDICAL CENTER1GENZYME CORP1
Top patents by PatentIndex Score
54 records- 0187US7208273B2Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmiaUNIV UTAH RES FOUND·Filed 2001·Granted Apr 24, 2007·14 cites·7 claims
- 0286US6582913B1Diagnostic method for KVLQT1—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 2000·Granted Jun 24, 2003·9 cites·16 claims
- 0386US6342357B1Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting sameUNIV UTAH RES FOUND·Filed 2000·Granted Jan 29, 2002·11 cites·17 claims
- 0484US6787309B2Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting sameUNIV UTAH RES FOUND·Filed 2001·Granted Sep 7, 2004·14 cites·17 claims
- 0584US6451534B1KVLQT1—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 2000·Granted Sep 17, 2002·8 cites·12 claims
- 0682US12331297B2Coagulation factor V (F5) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Jun 17, 2025·0 cites·28 claims
- 0782US12258565B2Complement component C3 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Mar 25, 2025·0 cites·28 claims
- 0882US11034957B2Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Jun 15, 2021·1 cites·30 claims
- 0982US6420124B1KVLQT1—a long qt syndrome geneUNIV UTAH RES FOUND·Filed 2000·Granted Jul 16, 2002·6 cites·7 claims
- 1082US6274332B1Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT geneUNIV OF UTAH RES FOUNDATION·Filed 1998·Granted Aug 14, 2001·31 cites·14 claims
- 1182US5599673ALong QT syndrome genesUNIV UTAH RES FOUND·Filed 1995·Granted Feb 4, 1997·46 cites·32 claims
- 1279US12473550B2Coagulation factor V (F5) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted Nov 18, 2025·0 cites·55 claims
- 1378US6207383B1Mutations in and genomic structure of HERG—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 1999·Granted Mar 27, 2001·25 cites·16 claims
- 1477US6277978B1KVLQT1—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 1998·Granted Aug 21, 2001·18 cites·43 claims
- 1576US6432644B1Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT geneUNIV UTAH RES FOUND·Filed 1999·Granted Aug 13, 2002·20 cites·13 claims
- 1676US2024200061A1TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1774US12365896B2Complement component C3 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Jul 22, 2025·0 cites·52 claims
- 1873US7125837B1Elastin-based compositionsUNIV UTAH RES FOUND·Filed 2000·Granted Oct 24, 2006·15 cites·35 claims
- 1972US6372958B1Transgenic mouse with endogenous endoglin gene disruptionUNIV UTAH RES FOUND·Filed 2000·Granted Apr 16, 2002·10 cites·8 claims
- 2071US11878060B2mRNA-mediated immunization methodsNOVARTIS AG·Filed 2017·Granted Jan 23, 2024·1 cites·13 claims
- 2171US6864364B1MinK-related genes, formation of potassium channels and association with cardiac arrhythmiaUNIV UTAH RES FOUND·Filed 2000·Granted Mar 8, 2005·4 cites·13 claims
- 2268US7247436B2Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT geneUNIV UTAH RES FOUND·Filed 2004·Granted Jul 24, 2007·0 cites·11 claims
- 2368US6323026B1Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT geneUNIV UTAH RES FOUND·Filed 1999·Granted Nov 27, 2001·15 cites·18 claims
- 2468US2004235038A1Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT geneUNIV UTAH RES FOUND·Filed 2004·Application pending·0 cites
- 2565US7297489B2Mutations in and genomic structure of HERG—a long QT syndrome geneUNIV UTAH RES FOUND·Filed 2003·Granted Nov 20, 2007·0 cites·7 claims
- 2665US2022333104A1TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2764US7301067B2Mice which are +/− or −/− for the elastin gene as models for vascular diseaseUNIV UTAH RES FOUND·Filed 2005·Granted Nov 27, 2007·0 cites·6 claims
- 2863US2023272382A1COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING COMPLEMENT COMPONENT C3-ASSOCIATED DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2963US2022002724A1AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3063US2023304002A1TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3162US2024117348A1COAGULATION FACTOR X (F10) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3261US5650282ADiagnosis of Williams syndromeUNIV UTAH RES FOUND·Filed 1995·Granted Jul 22, 1997·20 cites·4 claims
- 3357US2023295622A1Compositions and methods for silencing myoc expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3456US6972176B2KVLQT1—a long QT syndrome geneGENZYME CORP·Filed 2003·Granted Dec 6, 2005·0 cites·1 claims
- 3556US2004197818A1MinK-related genes, formation of potassium channels and association with cardiac arrhythmiaUNIV UTAH RES FOUND·Filed 2004·Application pending·0 cites
- 3655US2025283071A1Modified double stranded oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3755US2024294906A1Atxn2 irna compositions and methods of use thereof for treating or preventing atxn2-associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3855US2001034024A1Mutations in and genomic structure of HERG - a long QT syndrome geneFiled 2000·Application pending·0 cites
- 3955US2023136787A1Compositions and methods for silencing vegf-a expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4054US5858662ADiagnosis of Williams syndrome and Williams syndrome cognitive profile by analysis of the presence or absence of a LIM-kinase geneUNIV UTAH RES FOUND·Filed 1996·Granted Jan 12, 1999·16 cites·15 claims
- 4151US2005003445A1Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting sameUNIV UTAH RES FOUND·Filed 2004·Application pending·0 cites
- 4249US2008227738A1Compositions and methods for cell dedifferentiation and tissue regenerationUNIV UTAH RES FOUND·Filed 2007·Application pending·0 cites
- 4348US6903244B1Mice which are +/− or −/− for the elastin gene as models for vascular diseaseUNIV UTAH RES FOUND·Filed 1999·Granted Jun 7, 2005·5 cites·2 claims
- 4448US2009175875A1Molecules and Methods for Modulating Complement ComponentNOVARTIS AG·Filed 2008·Application pending·0 cites
- 4547US6150104AHomozygous mutation in KVLQT1 which causes Jervell and Lange Nielsen syndromeUNIV UTAH RES FOUND·Filed 1998·Granted Nov 21, 2000·8 cites·34 claims
- 4647US2010166748A1C5 Antigens and Uses ThereofNOVARTIS AG·Filed 2008·Application pending·0 cites
- 4747US2002100071A1Transgenic mouse with endogenous endoglin gene disruptionFiled 2002·Application pending·0 cites
- 4844US2006281791A1Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibitionCHILDRENS MEDICAL CENTER·Filed 2006·Application pending·0 cites
- 4944US2010047204A1Use of organic compoundsYOO DANA SUE·Filed 2007·Application pending·0 cites
- 5042US2004087016A1Compositions and methods for cell dedifferentiation and tissue regenerationUNIV UTAH RES FOUND·Filed 2002·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →